Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baras

Showing results (311-320 of 499) with videos related to

Pageof 50
Sort By:
Human Molecular Genetics|November 21, 2009
Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cellsMonica Y Lee, Sean M Garvey, Alex S Baras, et al.
Plos One|November 25, 2015
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial CarcinomaAlexander S Baras, Nilay Gandhi, Enrico Munari, et al.
Intensive Care Medicine|July 26, 2005
Communication of end-of-life decisions in European intensive care unitsSimon Cohen, Charles Sprung, Peter Sjokvist, et al.
Neoplasia (New York, N.Y.)|July 6, 2006
Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activationM Firdos Ziauddin, Wen-Shuz Yeow, Justin B Maxhimer, et al.
Urologic Oncology|September 19, 2016
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?Aaron Brant, Max Kates, Meera R Chappidi, et al.
Endocrine-Related Cancer|February 8, 2020
FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cellsHiroki Ide, Taichi Mizushima, Guiyang Jiang, et al.
Communications Medicine|April 24, 2026
Polygenic risk score and 20-year prostate cancer-specific mortality and survivalAnna Plym, Anqi Wang, Konrad H Stopsack, et al.
Materials (Basel, Switzerland)|March 4, 2020
Novel Bioactive and Therapeutic Root Canal Sealers with Antibacterial and Remineralization PropertiesBashayer H Baras, Mary Anne S Melo, Vivek Thumbigere-Math, et al.
Critical Care Medicine|December 20, 2007
Relieving suffering or intentionally hastening death: where do you draw the line?Charles L Sprung, Didier Ledoux, Hans-Henrik Bulow, et al.
Briefings in Bioinformatics|August 23, 2024
Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncologyHaoyang Mi, Shamilene Sivagnanam, Won Jin Ho, et al.
Pageof 50

Showing results (311-320 of 499) with videos related to

Sort By:
Pageof 50
Human Molecular Genetics|November 21, 2009
Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cellsMonica Y Lee, Sean M Garvey, Alex S Baras, et al.
Plos One|November 25, 2015
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial CarcinomaAlexander S Baras, Nilay Gandhi, Enrico Munari, et al.
Intensive Care Medicine|July 26, 2005
Communication of end-of-life decisions in European intensive care unitsSimon Cohen, Charles Sprung, Peter Sjokvist, et al.
Neoplasia (New York, N.Y.)|July 6, 2006
Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activationM Firdos Ziauddin, Wen-Shuz Yeow, Justin B Maxhimer, et al.
Urologic Oncology|September 19, 2016
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?Aaron Brant, Max Kates, Meera R Chappidi, et al.
Endocrine-Related Cancer|February 8, 2020
FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cellsHiroki Ide, Taichi Mizushima, Guiyang Jiang, et al.
Communications Medicine|April 24, 2026
Polygenic risk score and 20-year prostate cancer-specific mortality and survivalAnna Plym, Anqi Wang, Konrad H Stopsack, et al.
Materials (Basel, Switzerland)|March 4, 2020
Novel Bioactive and Therapeutic Root Canal Sealers with Antibacterial and Remineralization PropertiesBashayer H Baras, Mary Anne S Melo, Vivek Thumbigere-Math, et al.
Critical Care Medicine|December 20, 2007
Relieving suffering or intentionally hastening death: where do you draw the line?Charles L Sprung, Didier Ledoux, Hans-Henrik Bulow, et al.
Briefings in Bioinformatics|August 23, 2024
Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncologyHaoyang Mi, Shamilene Sivagnanam, Won Jin Ho, et al.
Pageof 50